Article
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence.
Nature cancer - 1 Nov 2025
Tsanov Kaloyan M, Barriga Francisco M, Ho Yu-Jui, Alonso-Curbelo Direna, Livshits Geulah, Tian Sha, Koche Richard P, Baslan Timour, Simon Janelle, Wuest Alexandra N, Reyes José, Park Jin, Luan Wei, Wilkinson John E, Bhanot Umesh, Ray-Kirton Jordana, Masilionis Ignas, Dimitrova Nevenka, Iacobuzio-Donahue Christine A, Chaligné Ronan, Pe'er Dana, Massagué Joan, Lowe Scott W
Abstract excerpt
The role of driver gene mutations in sustaining tumor growth at metastatic sites is poorly understood. SMAD4 inactivation is a paradigm of such mutations and a hallmark of pancreatic ductal adenocarcinoma (PDAC). To determine whether metastatic tumors are dependent on SMAD4 inactivation, we developed a mouse model of PDAC that enables spatiotemporal control of Smad4 expression. While Smad4 inactivation in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
